Breaking News
Top News
-
H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN)
-
Ultragenyx Pharmaceutical (RARE) Garnering Bullish Sentiment With Forthcoming GTX-102 Phase 3 Angelman Trial
-
What Makes Denali Therapeutics (DNLI) One of the Best Biotech Stocks to Invest in
-
Optimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for Ulixacaltamide
-
Galaxy Digital Leads Investment In Blockchain Startup Fence
-
German, Spanish Inflation Reach Multiyear Highs
-
Oil Rises as US-Iran Standoff Threatens Prolonged Supply Shock
-
Bank Groups Eye Changes to Fed’s Relaxed Capital Plans
-
Trump Signals No Letup of Naval Blockade, Tech Results on Deck | The Opening Trade 4/29/2026
-
European Sugar Rift Deepens Over Plan to Curb Duty-Free Imports
-
Kalshi, Polymarket Face New Rival in Crypto’s Hottest Exchange
-
US Core Capital Goods Orders Jump by Most Since 2020
-
Citi Picks Veteran Mideast Banker Tannir for Top Regional Role
-
Trump’s $1.5 Trillion Defense Budget Faces GOP Pushback
-
AbbVie Raises FY Guidance on Immunology, Neuroscience Growth
-
Lululemon Founder Takes Aim at New CEO Pick, Escalates Proxy Fight
-
What Makes Meta Platforms (META) a Lucrative Investment?
-
Is MSFT a “Baby Thrown Out with the Bath Water” Stock?
-
Americans break with the world in naming country’s biggest problem (hint: it’s not the economy). Here’s our top worry
-
‘Sell in May and Go Away?’ Not So Fast, Says Signal
2026-02-05












